NMPA Approval

Bepotastine Besilate Orally Disintegrating Tablets

Approval Number

国药准字H20233733

Company宏越科技（湖州）有限公司

Registration Date

June 14, 2023

Drug Information

Generic Name

苯磺贝他斯汀口崩片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

June 14, 2023

Company Information

Applicant Company

Company Name宏越科技（湖州）有限公司

Company Address

浙江省湖州市龙溪街道王母山路1800号1号楼218

Manufacturing Company

Company Name浙江贝得药业有限公司

Company Address

浙江省绍兴市越城区袍江工业区三江路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

苯磺贝他斯汀口崩片 - NMPA 批准文号 | MedPath